127 related articles for article (PubMed ID: 38821306)
1. Design and discovery of anthranilamide derivatives as a potential treatment for neurodegenerative disorders via targeting cholinesterases and monoamine oxidases.
Zaib S; Khan I; Ali HS; Younas MT; Ibrar A; Al-Odayni AB; Al-Kahtani AA
Int J Biol Macromol; 2024 Jun; 272(Pt 1):132748. PubMed ID: 38821306
[TBL] [Abstract][Full Text] [Related]
2. Sulfonyl thioureas with a benzo[d]thiazole ring as dual acetylcholinesterase/butyrylcholinesterase and human monoamine oxidase A and B inhibitors: An in vitro and in silico study.
Dinh Thanh N; Son Hai D; Ngoc Toan V; Thi Kim Van H; Thi Kim Giang N; Minh Tri N
Arch Pharm (Weinheim); 2024 May; 357(5):e2300557. PubMed ID: 38321839
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis, and pharmacological evaluation of 2-amino-5-nitrothiazole derived semicarbazones as dual inhibitors of monoamine oxidase and cholinesterase: effect of the size of aryl binding site.
Tripathi RKP; M Sasi V; Gupta SK; Krishnamurthy S; Ayyannan SR
J Enzyme Inhib Med Chem; 2018 Dec; 33(1):37-57. PubMed ID: 29098902
[TBL] [Abstract][Full Text] [Related]
4. Novel propargylamine-based inhibitors of cholinesterases and monoamine oxidases: Synthesis, biological evaluation and docking study.
Krátký M; Vu QA; Štěpánková Š; Maruca A; Silva TB; Ambrož M; Pflégr V; Rocca R; Svrčková K; Alcaro S; Borges F; Vinšová J
Bioorg Chem; 2021 Nov; 116():105301. PubMed ID: 34492558
[TBL] [Abstract][Full Text] [Related]
5. In vitro and in vivo Biological Evaluation of Newly Tacrine-Selegiline Hybrids as Multi-Target Inhibitors of Cholinesterases and Monoamine Oxidases for Alzheimer's Disease.
Huang ST; Luo JC; Zhong GH; Teng LP; Yang CY; Tang CL; Jing L; Zhou ZB; Liu J; Jiang N
Drug Des Devel Ther; 2024; 18():133-159. PubMed ID: 38283137
[TBL] [Abstract][Full Text] [Related]
6. Exploration of a library of piperonylic acid-derived hydrazones possessing variable aryl functionalities as potent dual cholinesterase and monoamine oxidase inhibitors.
Kumar VP; Vishnu MS; Kumar S; Jaiswal S; Ayyannan SR
Mol Divers; 2023 Dec; 27(6):2465-2489. PubMed ID: 36355337
[TBL] [Abstract][Full Text] [Related]
7. Quinolinic Carboxylic Acid Derivatives as Potential Multi-target Compounds for Neurodegeneration: Monoamine Oxidase and Cholinesterase Inhibition.
Khan NA; Khan I; Abid SMA; Zaib S; Ibrar A; Andleeb H; Hameed S; Iqbal J
Med Chem; 2018; 14(1):74-85. PubMed ID: 28545383
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis, pharmacological evaluation, QSAR analysis, molecular modeling and ADMET of novel donepezil-indolyl hybrids as multipotent cholinesterase/monoamine oxidase inhibitors for the potential treatment of Alzheimer's disease.
Bautista-Aguilera OM; Esteban G; Bolea I; Nikolic K; Agbaba D; Moraleda I; Iriepa I; Samadi A; Soriano E; Unzeta M; Marco-Contelles J
Eur J Med Chem; 2014 Mar; 75():82-95. PubMed ID: 24530494
[TBL] [Abstract][Full Text] [Related]
9. Benzimidazole-derived carbohydrazones as dual monoamine oxidases and acetylcholinesterase inhibitors: design, synthesis, and evaluation.
Kumar S; Jaiswal S; Gupta SK; Ayyannan SR
J Biomol Struct Dyn; 2024 Jun; 42(9):4710-4729. PubMed ID: 37345530
[TBL] [Abstract][Full Text] [Related]
10. Multipotent MAO and cholinesterase inhibitors for the treatment of Alzheimer's disease: synthesis, pharmacological analysis and molecular modeling of heterocyclic substituted alkyl and cycloalkyl propargyl amine.
Samadi A; de los Ríos C; Bolea I; Chioua M; Iriepa I; Moraleda I; Bartolini M; Andrisano V; Gálvez E; Valderas C; Unzeta M; Marco-Contelles J
Eur J Med Chem; 2012 Jun; 52():251-62. PubMed ID: 22503231
[TBL] [Abstract][Full Text] [Related]
11. Exploration of a Library of 3,4-(Methylenedioxy)aniline-Derived Semicarbazones as Dual Inhibitors of Monoamine Oxidase and Acetylcholinesterase: Design, Synthesis, and Evaluation.
Tripathi RK; Rai GK; Ayyannan SR
ChemMedChem; 2016 Jun; 11(11):1145-60. PubMed ID: 27135466
[TBL] [Abstract][Full Text] [Related]
12. Pyrimidine-morpholine hybrids as potent druggable therapeutics for Alzheimer's disease: Synthesis, biochemical and in silico analyses.
Zaib S; Younas MT; Khan I; Ali HS; McAdam CJ; White JM; Jaber F; Awwad NS; Ibrahium HA
Bioorg Chem; 2023 Dec; 141():106868. PubMed ID: 37738768
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis and biological evaluation of phthalimide-alkylamine derivatives as balanced multifunctional cholinesterase and monoamine oxidase-B inhibitors for the treatment of Alzheimer's disease.
Sang Z; Wang K; Wang H; Yu L; Wang H; Ma Q; Ye M; Han X; Liu W
Bioorg Med Chem Lett; 2017 Nov; 27(22):5053-5059. PubMed ID: 29033232
[TBL] [Abstract][Full Text] [Related]
14. Deep eutectic solvent mediated synthesis of 3,4-dihydropyrimidin-2(1H)-ones and evaluation of biological activities targeting neurodegenerative disorders.
Saleem Khan M; Asif Nawaz M; Jalil S; Rashid F; Hameed A; Asari A; Mohamad H; Ur Rehman A; Iftikhar M; Iqbal J; Al-Rashida M
Bioorg Chem; 2022 Jan; 118():105457. PubMed ID: 34798458
[TBL] [Abstract][Full Text] [Related]
15. Structure-Based Design and Optimization of Multitarget-Directed 2H-Chromen-2-one Derivatives as Potent Inhibitors of Monoamine Oxidase B and Cholinesterases.
Farina R; Pisani L; Catto M; Nicolotti O; Gadaleta D; Denora N; Soto-Otero R; Mendez-Alvarez E; Passos CS; Muncipinto G; Altomare CD; Nurisso A; Carrupt PA; Carotti A
J Med Chem; 2015 Jul; 58(14):5561-78. PubMed ID: 26107513
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and biological evaluation of new pyrazolone Schiff bases as monoamine oxidase and cholinesterase inhibitors.
Tok F; Koçyiğit-Kaymakçıoğlu B; Sağlık BN; Levent S; Özkay Y; Kaplancıklı ZA
Bioorg Chem; 2019 Mar; 84():41-50. PubMed ID: 30481645
[TBL] [Abstract][Full Text] [Related]
17. Experimental and Computational Evaluation of Piperonylic Acid Derived Hydrazones Bearing Isatin Moieties as Dual Inhibitors of Cholinesterases and Monoamine Oxidases.
Vishnu MS; Pavankumar V; Kumar S; Raja AS
ChemMedChem; 2019 Jul; 14(14):1359-1376. PubMed ID: 31177620
[TBL] [Abstract][Full Text] [Related]
18. Indole alkaloids of Psychotria as multifunctional cholinesterases and monoamine oxidases inhibitors.
Passos CS; Simões-Pires CA; Nurisso A; Soldi TC; Kato L; de Oliveira CM; de Faria EO; Marcourt L; Gottfried C; Carrupt PA; Henriques AT
Phytochemistry; 2013 Feb; 86():8-20. PubMed ID: 23261030
[TBL] [Abstract][Full Text] [Related]
19. 4,6-Diphenylpyrimidine Derivatives as Dual Inhibitors of Monoamine Oxidase and Acetylcholinesterase for the Treatment of Alzheimer's Disease.
Kumar B; Dwivedi AR; Sarkar B; Gupta SK; Krishnamurthy S; Mantha AK; Parkash J; Kumar V
ACS Chem Neurosci; 2019 Jan; 10(1):252-265. PubMed ID: 30296051
[TBL] [Abstract][Full Text] [Related]
20. Selected 1,3-Benzodioxine-Containing Chalcones as Multipotent Oxidase and Acetylcholinesterase Inhibitors.
Jeong GS; Kaipakasseri S; Lee SR; Marraiki N; Batiha GE; Dev S; Palakkathondi A; Kavully FS; Gambacorta N; Nicolotti O; Mathew B; Kim H
ChemMedChem; 2020 Dec; 15(23):2257-2263. PubMed ID: 32924264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
